Carlo Patrono

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 83

Top Topics

Cardiovascular Disease

Acute Myocardial Infarction

Helicobacter Pylori

Top Venues

European heart journal

Nature reviews. Cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Carlo Patrono
Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease. European heart journal 45 (27) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area. European heart journal 45 (27) (2024)
Giovanna Liuzzo, Carlo Patrono
Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation. European heart journal (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area. European heart journal 45 (27) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful lifestyle intervention. European heart journal (2024)
Massimo Volpe, Carlo Patrono
Discontinuation of renin-angiotensin system inhibitors brings no benefits in severe chronic kidney disease. European heart journal 45 (26) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly journal scan: it takes two for acute stroke. European heart journal 45 (20) (2024)
Massimo Volpe, Carlo Patrono
Discontinuation of renin-angiotensin system inhibitors brings no benefits in severe chronic kidney disease. European heart journal 45 (26) (2024)
Carlo Patrono
Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease. European heart journal 45 (27) (2024)
Giovanna Petrucci, Georgina A Buck, Bianca Rocca, Sarah Parish, Colin Baigent, Duaa Hatem, Marion M Mafham, Aida Habib, Louise Bowman, Jane Armitage, Carlo Patrono
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial. European heart journal (2024)
Carlo Patrono
Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease. European heart journal 45 (27) (2024)
Carlo Patrono
Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease. European heart journal (2024)
Giovanna Petrucci, Georgina A Buck, Bianca Rocca, Sarah Parish, Colin Baigent, Duaa Hatem, Marion M Mafham, Aida Habib, Louise Bowman, Jane Armitage, Carlo Patrono
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial. European heart journal 45 (15) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes? European heart journal (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly Journal Scan: Plastic particles in carotid plaques-inactive debris or predictors of cardiovascular events? European heart journal (2024)
Rocco Vergallo, Carlo Patrono
Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time? European heart journal (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly journal scan: it takes two for acute stroke. European heart journal (2024)
Rocco Vergallo, Carlo Patrono
Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time? European heart journal 45 (25) (2024)
Giovanna Liuzzo, Carlo Patrono
Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation. European heart journal 45 (10) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area. European heart journal 45 (27) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early vascular events after acute myocardial infarction. European heart journal (2024)
Massimo Volpe, Carlo Patrono
Discontinuation of renin-angiotensin system inhibitors brings no benefits in severe chronic kidney disease. European heart journal (2024)
Rocco Vergallo, Carlo Patrono
Weekly Journal Scan: incremental utility of circulating biomarkers for cardiovascular risk prediction. European heart journal (2024)
Giovanna Liuzzo, Carlo Patrono
Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT few. European heart journal 45 (8) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly Journal Scan: Plastic particles in carotid plaques-inactive debris or predictors of cardiovascular events? European heart journal 45 (32) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly Journal Scan: tirzepatide SURMOUNTs obesity-related obstructive sleep apnoea. European heart journal (2024)
Massimo Volpe, Carlo Patrono
Discontinuation of renin-angiotensin system inhibitors brings no benefits in severe chronic kidney disease. European heart journal 45 (26) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful lifestyle intervention. European heart journal 45 (16) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly journal scan: it takes two for acute stroke. European heart journal 45 (20) (2024)
Giovanna Liuzzo, Carlo Patrono
Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area. European heart journal (2024)
Giovanna Liuzzo, Carlo Patrono
Helicobacter pylori eradication as a gastroprotective strategy in elderly aspirin-treated subjects: established facts and unanswered questions. European heart journal 44 (9) (2023)
Massimo Volpe, Carlo Patrono
The promise of selective aldosterone synthase inhibition for the management of resistant hypertension. European heart journal 44 (8) (2023)
Giovanna Liuzzo, Carlo Patrono
Five easy pieces only account for a fraction of incident cardiovascular disease and all-cause deaths. European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Edoxaban for atrial high-rate episodes: more harm than good? European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease. European heart journal 44 (12) (2023)
Rocco Vergallo, Carlo Patrono
Lower income, higher risk: disparities in treatments and outcomes of patients with acute myocardial infarction. European heart journal (2023)
Massimo Volpe, Carlo Patrono
Bempedoic acid: a CLEAR therapeutic option for statin-intolerant patients? European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Targeting residual cardiovascular risk in the statin era: cholesterol or inflammation? European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT few. European heart journal (2023)
Rocco Vergallo, Carlo Patrono
Machine learning and myocardial infarction diagnosis: sometimes you can't make it on your own. European heart journal (2023)
Rocco Vergallo, Carlo Patrono
Aspirin for venous thromboprophylaxis after fracture: ready for prime time? European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation. European heart journal 44 (6) (2023)
Rocco Vergallo, Carlo Patrono
Heart failure and socioeconomic status: global differences and inequalities. European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Moving a STEP forward in the treatment of patients with obesity and heart failure with preserved ejection fraction. European heart journal (2023)
Rocco Vergallo, Carlo Patrono
Cardiovascular disease prevention in people living with HIV: from REPRIEVE to a statin of grace. European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Helicobacter pylori eradication as a gastroprotective strategy in elderly aspirin-treated subjects: established facts and unanswered questions. European heart journal (2023)
Daniela Pedicino, Carlo Patrono
Adverse effects of anthracyclines: does atorvastatin STOP-CArdiotoxicity? European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Acute myocardial infarction is associated with faster age-related cognitive decline. European heart journal (2023)
Rocco Vergallo, Carlo Patrono
'Atom Heart Mothers': the risk of ischaemic heart disease in women with adverse pregnancy outcomes. European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease. European heart journal (2023)
Giovanna Liuzzo, Carlo Patrono
Give genotype-guided dual antiplatelet therapy a second CHANCE. European heart journal 43 (10) (2022)
Francesco Paneni, Carlo Patrono
Increased risk of incident diabetes in patients with long COVID. European heart journal 43 (22) (2022)
Giovanna Liuzzo, Carlo Patrono
A SECURE polypill as a strategy at the heart of secondary prevention. European heart journal 43 (43) (2022)
Leonarda Galiuto, Carlo Patrono
Differential cardiovascular effects of disease-modifying antirheumatic drugs in rheumatoid arthritis. European heart journal 43 (17) (2022)
Felicita Andreotti, Tobias Geisler, Jean Philippe Collet, Bruna Gigante, Diana A Gorog, Sigrun Halvorsen, Gregory Y H Lip, Joao Morais, Eliano Pio Navarese, Carlo Patrono, Bianca Rocca, Andrea Rubboli, Dirk Sibbing, Robert F Storey, Freek W A Verheugt, Gemma Vilahur
Acute, periprocedural and longterm antithrombotic therapy in older adults. European heart journal (2022)
Giovanna Liuzzo, Carlo Patrono
In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failure. European heart journal 43 (16) (2022)
Giovanna Liuzzo, Carlo Patrono
The absolute cardiovascular benefits of PCSK9 inhibitors and ezetimibe added to maximally tolerated statin therapy depend on individual baseline cardiovascular risk. European heart journal 43 (32) (2022)
Giovanna Liuzzo, Carlo Patrono
Can targeting factor XIa dissociate thrombosis from haemostasis? European heart journal 43 (11) (2022)
Carlo Patrono
Aspirin: 1A @ 125. European heart journal 43 (34) (2022)
Giovanna Liuzzo, Carlo Patrono
Dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonism for substantial body weight reduction in obese subjects. European heart journal 43 (35) (2022)
Leonarda Galiuto, Carlo Patrono
Efficacy of a Mediterranean diet for the secondary prevention of cardiovascular disease. European heart journal 43 (29) (2022)
Massimo Volpe, Carlo Patrono
One-shot thrombolysis for the management of acute ischaemic stroke. European heart journal 43 (38) (2022)
Giovanna Liuzzo, Carlo Patrono
Long-term use of proton pump inhibitors and risk of diabetes mellitus: the totality of the evidence does not support a change in practice. European heart journal 43 (40) (2022)
Massimo Volpe, Carlo Patrono
Blood pressure lowering drugs differ in their capacity to prevent type 2 diabetes. European heart journal 43 (12) (2022)
Massimo Volpe, Carlo Patrono
Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management? European heart journal 42 (48) (2022)
Massimo Volpe, Carlo Patrono
Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges. European heart journal (2022)
Giovanna Liuzzo, Carlo Patrono
Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation. European heart journal (2022)
Massimo Volpe, Carlo Patrono
Age-independent benefits of blood pressure lowering: are they applicable to all patients? European heart journal 43 (6) (2022)
Rocco Vergallo, Carlo Patrono
A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction. European heart journal (2022)
Giovanna Liuzzo, Carlo Patrono
Placing the risk of myopericarditis following COVID-19 vaccination into perspective. European heart journal 43 (27) (2022)
Massimo Volpe, Carlo Patrono
Drugs may worsen blood pressure control: focus on the underestimated role of non-steroidal anti-inflammatory drugs. European heart journal 43 (14) (2022)
Rocco Vergallo, Carlo Patrono
The PACMAN-AMI trial: game over for the "vulnerable plaque"? European heart journal 43 (23) (2022)
Massimo Volpe, Carlo Patrono
The promise of selective aldosterone synthase inhibition for the management of resistant hypertension. European heart journal (2022)
Giovanna Liuzzo, Carlo Patrono
Solid evidence that very few muscle symptoms are due to statin therapy. European heart journal (2022)
Giovanna Liuzzo, Carlo Patrono
A fixed-dose combination treatment strategy to reduce premature cardiovascular disease deaths globally. European heart journal 43 (1) (2022)
Rocco Vergallo, Carlo Patrono
Antiplatelet therapy to prevent graft failure after coronary artery bypass graft: aspirin monotherapy for most, DAPT for selected few. European heart journal 43 (42) (2022)
Massimo Volpe, Carlo Patrono
The EMPEROR-Preserved study: end of the search for the "Phoenix" or beginning of a new season for trials in heart failure with preserved ejection fraction. European heart journal 42 (45) (2021)
Maria Lucia Narducci, Carlo Patrono
Abelacimab and factor XI inhibition: a novel mechanism for the prevention of venous thromboembolism. European heart journal 42 (40) (2021)
Massimo Volpe, Carlo Patrono
Another STEP towards tighter control of blood pressure in the elderly. European heart journal 42 (46) (2021)
Massimo Volpe, Carlo Patrono
The cardiovascular benefits of statins outweigh adverse effects in primary prevention: results of a large systematic review and meta-analysis. European heart journal 42 (44) (2021)
Francesco Paneni, Carlo Patrono
Is tirzepatide in the surpass lane over GLP-1 receptor agonists for the treatment of diabetes? European heart journal 42 (41) (2021)
Giovanna Liuzzo, Carlo Patrono
Does abbreviated dual antiplatelet therapy after PCI provide a clinically meaningful trade-off between bleeding and ischaemic events in patients at high risk for bleeding? European heart journal 42 (43) (2021)
Carlo Patrono, Colin Baigent
Role of aspirin in primary prevention of cardiovascular disease. Nature reviews. Cardiology 16 (11) (2019)